Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?

Circulation. 2020 Jun 16;141(24):1948-1950. doi: 10.1161/CIRCULATIONAHA.120.047122. Epub 2020 Apr 13.

Matthew J Daniels^{1

2

3}, Mauricio G Cohen⁴, Anthony A Bavry⁵, Dharam J Kumbhani⁵

¹ Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, UK (M.J.D.).
² Division of Cardiovascular Sciences, Manchester Academic Health Sciences Centre (M.J.D.), University of Manchester, UK.
³ Division of Cell Matrix Biology and Regenerative Medicine (M.J.D.), University of Manchester, UK.
⁴ Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, FL (M.G.C.).
⁵ Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (A.A.B., D.J.K.).

No abstract available

Keywords: COVID-19; ST elevation myocardial infarction; percutaneous coronary intervention.

Publication types